221 related articles for article (PubMed ID: 17195977)
1. A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data.
Hoch JS; Smith MW
J Trauma Stress; 2006 Dec; 19(6):787-97. PubMed ID: 17195977
[TBL] [Abstract][Full Text] [Related]
2. Posttraumatic stress disorder (PTSD) in the Armed Forces: health economic considerations.
McCrone P; Knapp M; Cawkill P
J Trauma Stress; 2003 Oct; 16(5):519-22. PubMed ID: 14584638
[TBL] [Abstract][Full Text] [Related]
3. Methodological assessment of economic evaluations of alcohol treatment: what is missing?
Barbosa C; Godfrey C; Parrott S
Alcohol Alcohol; 2010; 45(1):53-63. PubMed ID: 19808943
[TBL] [Abstract][Full Text] [Related]
4. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
Phillips KA; Hotlgrave DR
Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
[TBL] [Abstract][Full Text] [Related]
5. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
Hoerger TJ
Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
7. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation and the postponement of health care costs.
van Baal PH; Feenstra TL; Polder JJ; Hoogenveen RT; Brouwer WB
Health Econ; 2011 Apr; 20(4):432-45. PubMed ID: 21210494
[TBL] [Abstract][Full Text] [Related]
10. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
Wasem J; Hessel F; Kerim-Sade C
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
[TBL] [Abstract][Full Text] [Related]
11. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
12. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
Negrín MA; Vázquez-Polo FJ
J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
[TBL] [Abstract][Full Text] [Related]
13. How do we evaluate the economics of health care?
Kumar S; Williams AC; Sandy JR
Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
McGhan WF
Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis and innovation.
Jena AB; Philipson TJ
J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of cancer treatment costs: another tool for oncology managers.
Chirikos TN; Ruckdeschel JC; Krischer JP
J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
[TBL] [Abstract][Full Text] [Related]
17. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
Dougherty EJ
Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
[TBL] [Abstract][Full Text] [Related]
20. Improving efficiency and value in palliative care with net benefit regression: an introduction to a simple method for cost-effectiveness analysis with person-level data.
Hoch JS
J Pain Symptom Manage; 2009 Jul; 38(1):54-61. PubMed ID: 19615627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
